Table 2.

List of antiretroviral regimens analysed grouped by the third drug

Drugn%
NNRTI
 efavirenz164387.6
 nevirapine1045.5
 rilpivirine925.0
 etravirine372.0
 total NNRTI1876100
PI
 lopinavir42223.4
 nelfinavir23913.3
 atazanavir64235.6
 darunavir29116.1
 fosamprenavir492.7
 saquinavir281.6
 indinavir1226.8
 amprenavir110.6
 total PI1804100
INSTI
 raltegravir13145.0
 elvitegravir11840.6
 dolutegravir4214.4
 total INSTI291100
Drugn%
NNRTI
 efavirenz164387.6
 nevirapine1045.5
 rilpivirine925.0
 etravirine372.0
 total NNRTI1876100
PI
 lopinavir42223.4
 nelfinavir23913.3
 atazanavir64235.6
 darunavir29116.1
 fosamprenavir492.7
 saquinavir281.6
 indinavir1226.8
 amprenavir110.6
 total PI1804100
INSTI
 raltegravir13145.0
 elvitegravir11840.6
 dolutegravir4214.4
 total INSTI291100
Table 2.

List of antiretroviral regimens analysed grouped by the third drug

Drugn%
NNRTI
 efavirenz164387.6
 nevirapine1045.5
 rilpivirine925.0
 etravirine372.0
 total NNRTI1876100
PI
 lopinavir42223.4
 nelfinavir23913.3
 atazanavir64235.6
 darunavir29116.1
 fosamprenavir492.7
 saquinavir281.6
 indinavir1226.8
 amprenavir110.6
 total PI1804100
INSTI
 raltegravir13145.0
 elvitegravir11840.6
 dolutegravir4214.4
 total INSTI291100
Drugn%
NNRTI
 efavirenz164387.6
 nevirapine1045.5
 rilpivirine925.0
 etravirine372.0
 total NNRTI1876100
PI
 lopinavir42223.4
 nelfinavir23913.3
 atazanavir64235.6
 darunavir29116.1
 fosamprenavir492.7
 saquinavir281.6
 indinavir1226.8
 amprenavir110.6
 total PI1804100
INSTI
 raltegravir13145.0
 elvitegravir11840.6
 dolutegravir4214.4
 total INSTI291100
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close